Activation of CB1 and CB2 receptors attenuates the induction and maintenance of inflammatory pain in the rat

A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia

Hargreaves, K., Dubner, R. A., Brown, F. J., Flores, C., & Joris, J. L. (1988) · Pain · doi:10.1016/0304-3959(88)90026-7 · Cited by 5,155 · see citing works

Molecular characterization of a peripheral receptor for cannabinoids

Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · see citing works

Cannabinoid receptor localization in brain.

Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321 · see citing works

Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations

Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D. J., Fur, G. L., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,751 · see citing works

Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice

Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M. A., & Bonner, T. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5780 · Cited by 1,065 · see citing works

Control of pain initiation by endogenous cannabinoids

Calignano, A., Rana, G. L., Giuffrida, A., & Piomelli, D. (1998) · Nature · doi:10.1038/28393 · Cited by 1,055 · see citing works

Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.

Felder, C., Joyce, K. E., Briley, E. M., Mansouri, J., Mackie, K., Blond, O., Lai, Y., Ma, A. L., & Mitchell, R. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10492-6 · Cited by 900 · see citing works

Cannabinoid receptors and pain

Pertwee, R. G. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00031-9 · Cited by 741 · see citing works

SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor

Rinaldi, M. L., Barth, F., Millan, J., Derocq, J., Casellas, P., Congy, C., Oustric, D., Sarran, M., Bouaboula, M., Calandra, B., et al. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37266-0 · Cited by 708 · see citing works

HU-308: A specific agonist for CB 2 , a peripheral cannabinoid receptor

Hanus, L. O., Breuer, A., Tchilibon, S., Shiloah, S., Goldenberg, D., Horowitz, M., Pertwee, R. G., Ross, R. A., Mechoulam, R., & Fride, E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14228 · Cited by 574 · see citing works

Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors

Richardson, J. D., Kilo, S., & Hargreaves, K. (1998) · Pain · doi:10.1016/s0304-3959(97)00213-3 · Cited by 498 · see citing works

Preemptive Analgesia Clinical Evidence of Neuroplasticity Contributing to Postoperative Pain

Katz, J. D., Kavanagh, B. P., Sandler, A. N., Nierenberg, H., Boylan, J. F., Friedlander, M., & Shaw, B. F. (1992) · Anesthesiology · doi:10.1097/00000542-199209000-00006 · Cited by 482 · see citing works

Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models

Zhang, J., Hoffert, C., Vu, H. K., Groblewski, T., Ahmad, S., & O'Donnell, D. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02704.x · Cited by 419 · see citing works

CB2 cannabinoid receptor-mediated peripheral antinociception

Malan, P. T., Ibrahim, M. M., Deng, H., Liu, Q., Mata, H. P., Vanderah, T., Porreca, F., & Makriyannis, A. (2001) · Pain · doi:10.1016/s0304-3959(01)00321-9 · Cited by 391 · see citing works

The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain

Fox, A., Kesingland, A., Gentry, C., McNair, K., Patel, S., Urban, L., & James, I. (2001) · Pain · doi:10.1016/s0304-3959(00)00474-7 · Cited by 379 · see citing works

Biochemical and pharmacological characterisatioN OF SR141716A, the first potent and selective brain cannabinoid receptor antagonist

Rinaldi, M. L., Barth, F., Héaulme, M., Alonso, R., Shire, D. J., Congy, C., Soubrié, P., Brelière, J.-C., & Fur, G. L. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00174-5 · Cited by 303 · see citing works

Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study

Hohmann, A. G., & Herkenham, M. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00524-7 · Cited by 301 · see citing works

3-(1′,1′-Dimethylbutyl)-1-deoxy-Δ8-THC and related compounds: synthesis of selective ligands for the CB2 receptor

Huffman, J. W., Liddle, J., Yu, S., Aung, M. M., Abood, M. E., Wiley, J. L., & Martin, B. R. (1999) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(99)00219-9 · Cited by 290 · see citing works

Preoperative morphine pre-empts postoperative pain

Richmond, C. E., Bromley, L. M., & Woolf, C. J. (1993) · The Lancet · doi:10.1016/0140-6736(93)91284-s · Cited by 268 · see citing works

CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain

Clayton, N., Marshall, F. H., Bountra, C., & O'Shaughnessy, C. T. (2002) · Pain · doi:10.1016/s0304-3959(01)00454-7 · Cited by 247 · see citing works

Inhibition of Inflammatory Hyperalgesia by Activation of Peripheral CB2Cannabinoid Receptors

Quartilho, A., Mata, H. P., Ibrahim, M. M., Vanderah, T. W., Porreca, F., Makriyannis, A., & Malan, T. P. (2003) · Anesthesiology · doi:10.1097/00000542-200310000-00031 · Cited by 243 · see citing works

Enantiomeric cannabinoids: stereospecificity of psychotropic activity

Mechoulam, R., Feigenbaum, J. J., Lander, N., et al. (1988) · Cellular and Molecular Life Sciences · doi:10.1007/bf01959156 · Cited by 209 · see citing works

Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy

Rice, A. S. C., Farquhar-Smith, W. P., & Nagy, I. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0362 · Cited by 183 · see citing works

Selective activation of cannabinoid CB2 receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation

Nackley, A. G., Makriyannis, A., & Hohmann, A. G. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00126-x · Cited by 176 · see citing works

Cannabinoid CB₂ receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain

Elmes, S. J. R., Jhaveri, M. D., Smart, D., Kendall, D. A., & Chapman, V. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03690.x · Cited by 160 · see citing works

Cannabinoid receptors and reward in the rat: a conditioned place preference study

Cheer, J. F., Kendall, D. A., & Marsden, C. A. (2000) · Psychopharmacology · doi:10.1007/s002130000481 · Cited by 150 · see citing works

Stereochemical effects of 11-OH-Δ8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor

Howlett, A. C., Champion, T. M., Wilken, G. H., & Mechoulam, R. (1990) · Neuropharmacology · doi:10.1016/0028-3908(90)90056-w · Cited by 124 · see citing works

Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms

Johanek, L. M., Heitmiller, D. R., Turner, M., Nader, N., Hodges, J., & Simone, D. A. (2001) · Pain · doi:10.1016/s0304-3959(01)00336-0 · Cited by 83 · see citing works

Activation of spinal cannabinoid 1 receptors inhibits C‐fibre driven hyperexcitable neuronal responses and increases [35S]GTPγS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats

Drew, L., Harris, J. E., Millns, P. J., Kendall, D. A., & Chapman, V. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00101.x · Cited by 82 · see citing works

Electrophysiologic Analysis of Preemptive Effects of Spinal Opioids on N-methyl-D-aspartate Receptor-mediated Events

Chapman, V., Haley, J. E., & Dickenson, A. H. (1994) · Anesthesiology · doi:10.1097/00000542-199412000-00018 · Cited by 71 · see citing works

Activation of peripheral cannabinoid CB1 receptors inhibits mechanically evoked responses of spinal neurons in noninflamed rats and rats with hindpaw inflammation

Kelly, S., Jhaveri, M. D., Sagar, D. R., Kendall, D. A., & Chapman, V. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02957.x · Cited by 59 · see citing works

Cannabinoids as Analgesic Agents: Evidence from In Vivo Studies

Finn, D. P., & Chapman, V. (2004) · Current Neuropharmacology · doi:10.2174/1570159043476918 · Cited by 20 · see citing works

Preoperative morphine pre‐empts postoperative pain

Richmond, C. E., Bromley, L. M., & Woolf, C. J. (1994) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(94)90799-4 · Cited by 18 · see citing works

Cannabinoid CB ₂ receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain

Guindon, J., & Hohmann, A. G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707531 · Cited by 423 · see citing works

Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis

Richardson, D., Pearson, R. G., Kurian, N., Latif, M. L., Garle, M. J., Barrett, D. A., Kendall, D. A., Scammell, B. E., Reeve, A. J., & Chapman, V. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2401 · Cited by 303 · see citing works

The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain

Donvito, G., Nass, S. R., Wilkerson, J. L., Curry, Z. A., Schurman, L. D., Kinsey, S. G., & Lichtman, A. H. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.204 · Cited by 301 · see citing works

The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain

Staton, P. C., Hatcher, J. P., Walker, D. J., Morrison, A. D., Shapland, E. M., Hughes, J. P., Chong, E., Mander, P. K., Green, P. J., Billinton, A., et al. (2008) · Pain · doi:10.1016/j.pain.2008.04.006 · Cited by 270 · see citing works

The analgesic potential of cannabinoids.

Elikottil, M., Gupta, M., & Gupta, P. (2018) · Journal of Opioid Management · doi:10.5055/jom.2009.0034 · Cited by 141 · see citing works

Central and peripheral sites of action for CB ₂ receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats

Hsieh, G. C., Pai, M., Chandran, P., Hooker, B. A., Zhu, C. Z., Salyers, A. K., Wensink, E. J., Zhan, C., Carroll, W. A., Dart, M. J., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01046.x · Cited by 139 · see citing works

<i>In vitro</i>and<i>in vivo</i>characterization of A‐796260: a selective cannabinoid CB₂receptor agonist exhibiting analgesic activity in rodent pain models

Yao, B. B., Hsieh, G. C., Frost, J. M., Fan, Y., Garrison, T. R., Daza, A. V., Grayson, G. K., Zhu, C. Z., Pai, M., Chandran, P., et al. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707568 · Cited by 140 · see citing works

Characterization of a Cannabinoid CB2 Receptor-Selective Agonist, A-836339 [2,2,3,3-Tetramethyl-cyclopropanecarboxylic Acid [3-(2-Methoxy-ethyl)-4,5-dimethyl-3 H-thiazol-(2 Z)-ylidene]-amide], Using in Vitro Pharmacological Assays, in Vivo Pain Models, and Pharmacological Magnetic Resonance Imaging

Yao, B. B., Hsieh, G., Daza, A. V., Fan, Y., Grayson, G. K., Garrison, T. R., El Kouhen, O., Hooker, B. A., Pai, M., Wensink, E. J., et al. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.145011 · Cited by 92 · see citing works

Involvement of central cannabinoid CB2 receptor in reducing mechanical allodynia in a mouse model of neuropathic pain

Yamamoto, W., Mikami, T., & Iwamura, H. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.010 · Cited by 89 · see citing works

The synthetic cannabinoids attenuate allodynia and hyperalgesia in a rat model of trigeminal neuropathic pain

Liang, Y.-C., Huang, C.-C., & Hsu, K.-S. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.04.019 · Cited by 68 · see citing works

Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine inflammatory pain model

Anderson, W. B., Gould, M. J., Torres, R. D., Mitchell, V. A., & Vaughan, C. W. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.12.018 · Cited by 67 · see citing works

Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1(−/−) and not CB2(−/−) mice in models of acute and persistent pain

Sain, N. M. H., Liang, A., Kane, S. A., & Urban, M. O. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.06.004 · Cited by 51 · see citing works

A CB2 receptor agonist, A-836339, modulates wide dynamic range neuronal activity in neuropathic rats: Contributions of spinal and peripheral CB2 receptors

McGaraughty, S., Chu, K. L., Dart, M. J., Yao, B. B., & Meyer, M. D. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.015 · Cited by 31 · see citing works

Cannabinoid Ligand-Receptor Signaling During Early Pregnancy in the Mouse

Paria, B. C., Das, S., & Dey, S. K. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-710-9_40 · Cited by 3 · see citing works

Cannabinoid–improgan cross-tolerance: Improgan is a cannabinomimetic analgesic lacking affinity at the cannabinoid CB1 receptor

Nalwalk, J. W., Svokos, K. A., & Hough, L. B. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.08.035 · Cited by 9 · see citing works

Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes

Wiley, J. L., & Martin, B. R. (2002) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00146-9 · Cited by 100 · see citing works

Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles

Jansen, E. M., Haycock, D. A., Ward, S. J., & Seybold, V. S. (1992) · Brain Research · doi:10.1016/0006-8993(92)90428-c · Cited by 140 · see citing works

CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents

Haller, J., Varga, B., Ledent, C., & Freund, T. F. (2004) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000135704.56422.40 · Cited by 241 · see citing works